Next Article in Journal
Novel Therapeutic Approach to Induce Autophagy in a Drosophila Model for Huntington’s Disease
Previous Article in Journal
Ribosome and Translational Control in Stem Cells
Article

The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)

1
Department of Pharmaceutical Sciences, Università del Piemonte Orientale, 28100 Novara, Italy
2
Department of Pharmaceutical Sciences, Università di Pavia, 27100 Pavia, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally.
Cells 2020, 9(2), 496; https://doi.org/10.3390/cells9020496
Received: 15 November 2019 / Revised: 15 February 2020 / Accepted: 21 February 2020 / Published: 21 February 2020
(1) Background: Extracellular nicotinamide phosphoribosyltrasferase (eNAMPT) is released by various cell types with pro-tumoral and pro-inflammatory properties. In cancer, eNAMPT regulates tumor growth through the activation of intracellular pathways, suggesting that it acts through a putative receptor, although its nature is still elusive. It has been shown, using surface plasma resonance, that eNAMPT binds to the C-C chemokine receptor type 5 (CCR5), although the physiological meaning of this finding is unknown. The aim of the present work was to characterize the pharmacodynamics of eNAMPT on CCR5. (2) Methods: HeLa CCR5-overexpressing stable cell line and B16 melanoma cells were used. We focused on some phenotypic effects of CCR5 activation, such as calcium release and migration, to evaluate eNAMPT actions on this receptor. (3) Results: eNAMPT did not induce ERK activation or cytosolic Ca2+-rises alone. Furthermore, eNAMPT prevents CCR5 internalization mediated by Rantes. eNAMPT pretreatment inhibits CCR5-mediated PKC activation and Rantes-dependent calcium signaling. The effect of eNAMPT on CCR5 was specific, as the responses to ATP and carbachol were unaffected. This was strengthened by the observation that eNAMPT inhibited Rantes-induced Ca2+-rises and Rantes-induced migration in a melanoma cell line. (4) Conclusions: Our work shows that eNAMPT binds to CCR5 and acts as a natural antagonist of this receptor. View Full-Text
Keywords: eNAMPT; visfatin; CCR5; antagonism; cancer; calcium signaling; migration eNAMPT; visfatin; CCR5; antagonism; cancer; calcium signaling; migration
Show Figures

Graphical abstract

MDPI and ACS Style

Torretta, S.; Colombo, G.; Travelli, C.; Boumya, S.; Lim, D.; Genazzani, A.A.; Grolla, A.A. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5). Cells 2020, 9, 496. https://doi.org/10.3390/cells9020496

AMA Style

Torretta S, Colombo G, Travelli C, Boumya S, Lim D, Genazzani AA, Grolla AA. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5). Cells. 2020; 9(2):496. https://doi.org/10.3390/cells9020496

Chicago/Turabian Style

Torretta, Simone, Giorgia Colombo, Cristina Travelli, Sara Boumya, Dmitry Lim, Armando A. Genazzani, and Ambra A. Grolla 2020. "The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)" Cells 9, no. 2: 496. https://doi.org/10.3390/cells9020496

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop